MicroPort CardioFlow
Shanghai · Founded 2015
About MicroPort CardioFlow
Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $10K – $50K
- Total funding: $130.0M
- Funding stage: Private Equity
- Last round: Private Equity (Apr 2020)
- Website: http://www.cardioflowmedtech.com/
- Phone: + (86) (21) 38954600
Industries & Categories
Health Care, Manufacturing, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/microport-cardioflow-122586 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.